Carbimazole Drug Profile

What is Carbimazole?

Carbimazole is an antithyroid medication that belongs to a class of drugs called thionamides. It is primarily used to treat hyperthyroidism (overactive thyroid) by reducing the production of thyroid hormones. This medication is commonly prescribed for conditions such as Graves’ disease and toxic nodular goiter.

Uses

Carbimazole is approved for several thyroid-related conditions:

• Graves’ disease: The most common cause of hyperthyroidism, where the immune system stimulates excessive thyroid hormone production
• Toxic multinodular goiter: A condition where multiple thyroid nodules produce excess hormones
• Toxic adenoma: A single overactive thyroid nodule that produces too much thyroid hormone
• Preoperative thyroid preparation: Used before thyroid surgery to normalize hormone levels and reduce surgical risks
• Preparation for radioiodine therapy: Helps stabilize patients before radioactive iodine treatment for hyperthyroidism

How it works

Carbimazole works by inhibiting thyroid peroxidase, an enzyme essential for thyroid hormone synthesis. It blocks the incorporation of iodine into thyroglobulin, preventing the formation of thyroid hormones T3 and T4. The medication is converted to methimazole in the body, which is the active compound responsible for the antithyroid effects.

Side effects

Common side effects include:

Submit Your Paper

• Skin rash and itching
• Nausea and vomiting
• Headache
• Joint pain (arthralgia)
• Taste disturbances
• Hair loss
• Mild stomach upset
• Dizziness

Serious side effects requiring immediate medical attention:

• Agranulocytosis (severe reduction in white blood cells)
• Severe liver injury or hepatitis
• Severe skin reactions such as Stevens-Johnson syndrome
• Vasculitis (inflammation of blood vessels)
• Signs of infection (fever, sore throat, unusual fatigue)

Warnings and precautions

• Blood monitoring: Regular blood tests are essential to monitor white blood cell counts and liver function, especially during the first few months of treatment
• Pregnancy considerations: Carbimazole can cross the placenta and may cause fetal thyroid problems. Pregnant women should discuss alternative treatments with their healthcare provider
• Liver function: Patients with existing liver disease require careful monitoring as carbimazole can cause hepatotoxicity
• Infection risk: Patients should immediately report signs of infection, as the medication can suppress bone marrow function
• Breastfeeding: The drug passes into breast milk and may affect the nursing infant’s thyroid function

Interactions

Carbimazole can interact with several medications and substances:

• Warfarin and other anticoagulants: Carbimazole may enhance anticoagulant effects, increasing bleeding risk
• Theophylline: Thyroid status changes can affect theophylline clearance, requiring dose adjustments
• Digoxin: As thyroid function normalizes, digoxin levels may increase, potentially causing toxicity
• Beta-blockers: Effectiveness may change as thyroid function improves, requiring dose modifications
• Iodine-containing medications: Can reduce the effectiveness of carbimazole by providing substrate for thyroid hormone synthesis
• Lithium: May have additive antithyroid effects when used together
• Amiodarone: Contains high amounts of iodine and may counteract carbimazole’s effects
• Contrast agents: Iodinated contrast media can interfere with treatment effectiveness

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing for carbimazole varies based on the severity of hyperthyroidism and individual patient response. Initial doses usually range from 15-40 mg daily, often divided into multiple doses. Maintenance doses are typically lower, ranging from 5-15 mg daily once thyroid function normalizes. The medication is usually taken with food to minimize stomach upset. Dosage adjustments should always be made by a healthcare provider based on regular thyroid function tests and clinical response. Treatment duration varies but often continues for 12-18 months, with some patients requiring longer-term therapy.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).